Cargando…
Inciting inflammation: the RAGE about tumor promotion
Mechanisms of innate and adaptive immunity play a pivotal role in the development of cancer. Chronic inflammation can drive tumor development, but antitumor immunity can also restrict or even prevent tumor growth. New data show that feed-forward signals downstream of the receptor for advanced glycat...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271001/ https://www.ncbi.nlm.nih.gov/pubmed/18268042 http://dx.doi.org/10.1084/jem.20080136 |
_version_ | 1782151786016014336 |
---|---|
author | Dougan, Michael Dranoff, Glenn |
author_facet | Dougan, Michael Dranoff, Glenn |
author_sort | Dougan, Michael |
collection | PubMed |
description | Mechanisms of innate and adaptive immunity play a pivotal role in the development of cancer. Chronic inflammation can drive tumor development, but antitumor immunity can also restrict or even prevent tumor growth. New data show that feed-forward signals downstream of the receptor for advanced glycation end-products (RAGE) can fuel chronic inflammation, creating a microenvironment that is ideal for tumor formation. |
format | Text |
id | pubmed-2271001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22710012008-08-18 Inciting inflammation: the RAGE about tumor promotion Dougan, Michael Dranoff, Glenn J Exp Med Commentaries Mechanisms of innate and adaptive immunity play a pivotal role in the development of cancer. Chronic inflammation can drive tumor development, but antitumor immunity can also restrict or even prevent tumor growth. New data show that feed-forward signals downstream of the receptor for advanced glycation end-products (RAGE) can fuel chronic inflammation, creating a microenvironment that is ideal for tumor formation. The Rockefeller University Press 2008-02-18 /pmc/articles/PMC2271001/ /pubmed/18268042 http://dx.doi.org/10.1084/jem.20080136 Text en Copyright © 2008, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Commentaries Dougan, Michael Dranoff, Glenn Inciting inflammation: the RAGE about tumor promotion |
title | Inciting inflammation: the RAGE about tumor promotion |
title_full | Inciting inflammation: the RAGE about tumor promotion |
title_fullStr | Inciting inflammation: the RAGE about tumor promotion |
title_full_unstemmed | Inciting inflammation: the RAGE about tumor promotion |
title_short | Inciting inflammation: the RAGE about tumor promotion |
title_sort | inciting inflammation: the rage about tumor promotion |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271001/ https://www.ncbi.nlm.nih.gov/pubmed/18268042 http://dx.doi.org/10.1084/jem.20080136 |
work_keys_str_mv | AT douganmichael incitinginflammationtherageabouttumorpromotion AT dranoffglenn incitinginflammationtherageabouttumorpromotion |